RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma
Gianferante, M., Moore, A. L., Spector, L., Wheeler, W., Yang, T., Hubbard, A., Gorlick, R., Patiño-Garcia, A., Lecanda, F., Flanagan, A. M., Amary, F., Andrulis, IL., Wunder, J. S., Thomas, D., Ballinger, M. L., Serra, M., Hattinger, C., Demerath, E., Johnson, W., ... Mirabello, L. (2024). Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma. Cancer Epidemiology, 92, Article 102432. https://doi.org/10.1016/j.canep.2023.102432
Introduction: Several studies have linked increased risk of osteosarcoma with tall stature, high birthweight, and early puberty, although evidence is inconsistent. We used genetic risk scores (GRS) based on established genetic loci for these traits and evaluated associations between genetically inferred birthweight, height, and puberty timing with osteosarcoma. Methods: Using genotype data from two genome-wide association studies, totaling 1039 cases and 2923 controls of European ancestry, association analyses were conducted using logistic regression for each study and meta- analyzed to estimate pooled odds ratios (ORs) and 95% confidence intervals (CIs). Subgroup analyses were conducted by case diagnosis age, metastasis status, tumor location, tumor histology, and presence of a known pathogenic variant in a cancer susceptibility gene. Results: Genetically inferred higher birthweight was associated with an increased risk of osteosarcoma (OR =1.59, 95% CI 1.07-2.38, P =0.02). This association was strongest in cases without metastatic disease (OR =2.46, 95% CI 1.44-4.19, P =9.5 x10(-04)). Although there was no overall association between osteosarcoma and genetically inferred taller stature (OR=1.06, 95% CI 0.96-1.17, P =0.28), the GRS for taller stature was associated with an increased risk of osteosarcoma in 154 cases with a known pathogenic cancer susceptibility gene variant (OR=1.29, 95% CI 1.03-1.63, P =0.03). There were no significant associations between the GRS for puberty timing and osteosarcoma. Conclusion: A genetic propensity to higher birthweight was associated with increased osteosarcoma risk, suggesting that shared genetic factors or biological pathways that affect birthweight may contribute to osteosarcoma pathogenesis